🇺🇸 FDA
Patent

US 10342771

Creatine oral supplementation using creatine hydrochloride salt

granted A61KA61K31/185A61K31/195

Quick answer

US patent 10342771 (Creatine oral supplementation using creatine hydrochloride salt) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/185, A61K31/195, A61K31/198, A61K31/661